Extract

This study is being done to see how safe an investigational drug is and test how well it will work to help people with refractory/relapsed myelodysplastic syndrome (MDS) or chronic myelomonocytic leukemia (CMML).

Inclusion criteria

• Myelodysplastic syndrome (MDS),Chronic Myelomonocytic Leukemia (CMML)

Links

• ictrp
• nct